The Dangers of Transvaginal Mesh

Philadelphia and Allentown, Pennsylvania, New Jersey

As reports of complications associated with transvaginal mesh continue to increase, the Philadelphia product liability attorneys at Wapner, Newman, Wigrizer, Brecher & Miller are actively investigating claims from women who may have been injured by the medical devices following surgical treatment for stress urinary incontinence (SUI) or pelvic organ prolapse (POP).

Although transvaginal mesh was approved by the Food and Drug Administration (FDA) in 1996, reports of severe health complications and fatalities linked to transvaginal mesh have dramatically increased in recent years. While transvaginal mesh products remain on the market, the FDA issued an advisory in the summer of 2011 warning that mounting evidence indicates the devices are both potentially ineffective and dangerous.

Transvaginal mesh is surgically implanted through the vagina or abdomen and is intended to support pelvic organs in the treatment of POP or SUI. Complications associated with transvaginal mesh include:

• Transvaginal mesh migration
• Transvaginal mesh erosion into the vaginal wall
• Infections
• Internal bleeding
• Organ damage
• Vaginal pain
• Vaginal scarring
• Pain during urination
• Recurrence of SUI or POP

If not treated immediately, some of these side-effects can contribute to more severe health problems or wrongful death.

If you received transvaginal mesh in the surgical treatment of POP or SUI and later suffered complications, please contact the Pennsylvania and New Jersey product liability attorneys at Wapner, Newman, Wigrizer, Brecher & Miller for your free case evaluation. We have offices in Philadelphia, West Conshohocken, Allentown and Marlton.